Search Results

You are looking at 171 - 180 of 530 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Kevin O’Brien, Rahul Dave, Skand Shekhar, Fady Hannah-Shmouni, Leora E. Comis, Beth I. Solomon, Marcus Chen, William A. Gahl, Edmond FitzGibbon, Bernadette R. Gochuico, and Juvianee I. Estrada-Veras

, and perhaps neuropsychologic testing are important steps in the evaluation and treatment of these symptoms. 1 Organic brain pathology can cause psychiatric symptoms, 29 such as pseudobulbar affect in patients with ECD. 9 , 30 This neurologic

Full access

Marta Penas-Prado, Terri S. Armstrong, and Mark R. Gilbert

This was a hands-on multidisciplinary workshop in which clinicians, scientists, and advocacy partners met to discuss areas requiring further development, including understanding patients’ needs, deciphering the molecular pathology of adult

Full access

Julia R. Trosman, Christine B. Weldon, R. Kate Kelley, and Kathryn A. Phillips

with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology . J Mol Diagn 2012 ; 14 : 525 – 540 . 15. Manolio TA Chisholm RL Ozenberger B . Implementing genomic medicine in the clinic: the future is

Full access

Nadeem R. Abu-Rustum

Grade and Depth of Myometrial Invasion Pathology A key component of the added value of SLN procedures in endometrial cancer is enhanced pathology, also known as ultrastaging . At the authors’ institution, the protocol for SLN evaluation is

Full access

Heather H. Cheng, Alexandra O. Sokolova, Edward M. Schaeffer, Eric J. Small, and Celestia S. Higano

and F-18 fluciclovine PET scans may help distinguish patients with indolent versus occult metastatic disease. Figure 1 illustrates the interaction between clinical disease features, family history, and pathology to determine who should be offered

Full access

Daniel P. Mirda

personal connection, critical for a trusting and supportive relationship. Then, from various digital sources, we must evaluate pathology, genomics, imagining, and laboratory results to characterize our patient's condition. Then I use my knowledge and

Full access

David A. Kooby and Daniel G. Coit

the gastric cancer study in surgery and pathology. I. Clinical classification . Jpn J Surg 1981 ; 11 : 127 – 139 . 38 Soga J Kobayashi K Saito J . The role of lymphadenectomy in curative surgery for gastric cancer . World J Surg 1979

Full access

Andrew K. Lee and Christopher L. Amling

the data used to derive the model? Because nomograms are typically developed from retrospective data (with their inherent selection and reporting biases), the quality of the native data must be understood (e.g., was a central pathology review performed

Full access

Melinda Telli

addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathology complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Aliance) . J Clin

Full access

Dipesh Uprety and David E. Marinier

used for concurrent CRT, including cisplatin/etoposide, carboplatin/paclitaxel, cisplatin/vinblastine, and, for nonsquamous pathology, carboplatin or cisplatin with pemetrexed. 7 The carboplatin/paclitaxel regimen is given weekly with radiation therapy